Biosource International Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biosource International

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Peter H. Mack who wrote (148)	7/1/1997 6:15:00 PM
From: Peter H. Mack	of 696

I would like to throw these numbers out for comment.... Recently Biosource pre-announced a possible shortfall in earnings due to currency translation between US and European countries where they do substantial business. The projected amount of shortfall may be as much as 15%. Current analysts estimate for June places EPS at .11 for the quarter. Should .11 be actually achieved, then EPS(ttm) will work out to be .39. ( I have assumed that the 15% shortfall has been already accounted for in their estimates.) Building a table of past history.. qtr EPS (ttm) Price P/E(ttm) Mar 97 .37 7.19 19.43 Dec 96 .36 6.88 19.11 Sep 96 .34 9.00 26.47 Jun 96 .31 9.03 29.12 If the company meets current estimates, (.39 ttm) the price of this company should recover somewhat. Current running P/E is 17 which I would guess is based on lack of any exciting news. Anyone have a comment?? Pete Mack

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next